GRP and neoplasm: We discovered that Tle10 and NMe-His12 substitutions, either in combination or alone, can significantly enhance the in vivo stability and improve the tumor uptake of 68Ga-labeled GRPR agonists derived from the [Thz14]Bombesin(6–14) pharmacophore [22].